If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
260.00    -5.00 (-1.84%)
Bid:
255.00
Ask:
265.00
Spread: 10.00 (3.922%)
Market Cap: £242.55m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Trading Update

20 Jan 2026 07:00

RNS Number : 5087P
Concurrent Technologies PLC
20 January 2026
 

 20 January 2026

 

 

Concurrent Technologies Plc

("Concurrent", the "Company" or the "Group")

 

Trading Update

 

Significant year-on-year growth driven by record order intake

 

Concurrent Technologies Plc (AIM: CNC), a designer and manufacturer of leading-edge computer products, systems, and mission-critical solutions used in high-performance markets by some of the world's major OEMs, provides an update on trading for the year ended 31 December 2025 ("FY25").

 

Based on its unaudited management accounts, the Company expects both revenue and profit before tax to be in line with market expectations, delivering strong double-digit growth on FY24 (FY24: revenue £40.3m and profit before tax £5.2m).1 This reflects the growing momentum across the Group's Products and Systems business units, notwithstanding delays to US Department of Defense budget approvals and the recent US government shutdown.

 

Total order intake for FY25 was at a record level of approximately £47 million (FY24: £41 million), driven by particularly strong demand from customers in Europe and Asia-Pacific, reflecting the continued strengthening of Concurrent's reputation among leading global primes. The Group ended FY25 in a solid financial position with £14.4m of cash at bank (FY24: £13.7m), with elevated year-end debtors reflecting seasonally high invoicing.

 

In September, the Company announced a $5.2 million design services contract with a major defence prime contractor. A subsequent $1.0 million contract expansion has increased the total value to $6.2 million, making it Concurrent's largest single order to date. The expanded scope includes the design and supply of Automatic Test Equipment to support the customer's in-house production and testing, highlighting the early commercial success and growth potential of Concurrent's design services offering.

 

Outlook

The Company has entered the new financial year with good momentum, underpinned by robust customer demand, record order intake and a growing pipeline of design wins expected to convert into production revenues. This progress is supported by a solid balance sheet, providing the financial flexibility to continue investing as the Group delivers on its growth strategy in the year ahead, with strategic plans in place to manage component costs through the year as necessary.

 

Miles Adcock, CEO, commented: "FY25 was another strong year for Concurrent, in which we continued to execute on our stated strategy, as planned. With our new Los Angeles facilities now fully operational and the Colchester relocation expected to complete in H1 FY26, we believe the business is entering a new phase of operational capacity. We will see prior design wins begin translating into meaningful orders, while strengthening and diversifying our portfolio of products and services to support long-term growth. I am extremely proud of what our team has achieved and am excited by the scale of opportunity ahead."

 

1 As at 19 January 2026, The Board understands that market expectations for FY2025, based on published analyst forecasts, are for revenue of £46.0m, and profit before tax of £6.2m.

 

Enquiries:

Concurrent Technologies PlcMiles Adcock - CEO

Kim Garrod - CFO

 

 

 

+44 (0)1206 752626

Alma Strategic CommunicationsHannah Campbell

Josh Royston

Will Merison

 

 

+44 (0)20 3405 0205

Cavendish Capital Markets Limited (NOMAD)Neil McDonald

Peter Lynch

+44 (0)131 220 9771

+44 (0)131 220 9772

 

About Concurrent Technologies Plc

Concurrent Technologies Plc develops and manufactures high-end embedded plug-in cards and systems for use in a wide range of high-performance, long-life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products feature Intel® processors, including the latest generation embedded Intel® Core™ processors, Intel® Xeon® and Intel Atom™ processors. The products are designed to be compliant with industry specifications and support many of today's leading embedded operating systems. The products are sold world-wide.

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBLMLTMTJBBTF
Date   Source Headline
18th Jul 20237:00 amRNSPosting of Annual Report and Notice of AGM
17th Jul 20237:00 amRNSPost-Close Trading Update
30th Jun 20237:00 amRNSResults for the year ended 31 December 2022
19th Jun 20237:00 amRNSUpdate on Audited Annual Results
12th Jun 20237:00 amRNSSignificant Systems Win
9th Jun 20235:11 pmRNSNotification of Major Holdings
7th Jun 20237:00 amRNSNew Distributor Agreement
5th Jun 20237:00 amRNSNotice of Results
24th Mar 20237:00 amRNSNew Product Announcement
21st Mar 20237:00 amRNSReseller Agreement
4th Jan 20237:00 amRNSPost-Close Trading Update
14th Dec 20227:00 amRNSPartnership Agreement
28th Oct 20227:00 amRNSIssue of Share options and PDMR dealing
5th Oct 20227:00 amRNSConcurrent Technologies Enters the Systems Market
26th Sep 20227:00 amRNSInterim Results
12th Sep 20227:00 amRNSNotice of Interim Results
24th Aug 202210:29 amRNSHolding(s) in Company
24th Aug 202210:27 amRNSHolding(s) in Company
19th Aug 202212:06 pmRNSHolding(s) in Company
13th Jul 20227:00 amRNSSupply Agreement
29th Jun 202212:55 pmRNSResult of AGM
30th May 20227:00 amRNSPosting of Annual Report & Notice of AGM
23rd May 20222:46 pmRNSIssue of Share options and PDMR dealing
12th May 20227:00 amRNSResults for the year ended 31 December 2021
11th May 20227:00 amRNSInvestor Presentation
9th May 20227:00 amRNSConfirmation of Results Date and Board Appointment
24th Mar 202212:44 pmRNSNotice of Results
9th Mar 202210:36 amRNSContract Award
25th Feb 20227:00 amRNSProduct Announcement
21st Feb 20227:00 amRNSBoard Changes
26th Jan 20227:00 amRNSProduct Announcement
5th Jan 20227:00 amRNSPost-Close Trading Update
23rd Nov 20217:07 amRNSIssue of Share Options and PDMR Dealing
27th Sep 20213:12 pmRNSBoard Changes
7th Sep 20217:00 amRNSBoard Changes
7th Sep 20217:00 amRNSInterim Results
1st Sep 20211:20 pmRNSNotice of Results
10th Aug 202112:05 pmRNSHolding(s) in Company
4th Aug 20217:00 amRNSProduct Announcement
21st Jul 20217:00 amRNSBoard Changes
8th Jul 202111:15 amRNSHolding(s) in Company
23rd Jun 202111:58 amRNSIssue of share options and PDMR dealing
15th Jun 20214:19 pmRNSResult of AGM
15th Jun 202112:34 pmRNSAGM Statement
20th May 20217:00 amRNSPosting of Annual Report & Notice of AGM
12th May 20219:00 amRNSBoard Changes
12th Apr 20217:00 amRNSFinal Results
25th Mar 202110:50 amRNSNotification of Results
10th Mar 20217:00 amRNSSecond Interim Dividend
16th Dec 20207:00 amRNSPre-Close Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.